Cariprazine and Cognition in Patients with Schizophrenia and Bipolar Disorder: A Systematic Review

Simple item page
dc.contributor.authorGarcía Fernández, Lorena
dc.contributor.authorRomero Ferreiro, Verónica
dc.contributor.authorPeñuelas Calvo, Inmaculada
dc.contributor.authorÁlvarez Mon, Miguel Ángel
dc.contributor.authorScala, Mauro
dc.contributor.authorRomero Ferreiro, Carmen
dc.contributor.authorJiménez López, Estela
dc.contributor.authorSantos, José Luis
dc.contributor.authorRodríguez Jiménez, Roberto
dc.date.accessioned2024-12-10T19:32:09Z
dc.date.available2024-12-10T19:32:09Z
dc.date.issued2024
dc.description.abstractCariprazine (CAR), an antipsychotic with partial agonism at the D3 receptor and higher affinity than dopamine, has shown significant procognitive effects in preclinical animal studies. This study systematically reviews CAR's effects on cognitive measures in patients with schizophrenia and bipolar disorder.spa
dc.description.filiationUEMspa
dc.description.impact2.5 Q2 JCR 2023spa
dc.description.impact1.413 Q1 SJR 2023spa
dc.description.impactNo data IDR 2023spa
dc.description.sponsorshipThis research was supported in part by the Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), and CIBERSAMISCIII (Biomedical Research Networking Centre for Mental Health).spa
dc.identifier.citationGarcía-Fernández, L., Romero-Ferreiro, V., Peñuelas-Calvo, I., Álvarez-Mon, M. A., Scala, M., Romero-Ferreiro, C., López, E. J., Santos, J. L., & Rodriguez-Jimenez, R. (2024). Cariprazine and cognition in patients with schizophrenia and bipolar disorder: A systematic review. Harvard Review of Psychiatry, 32(6), 207-217. https://doi.org/10.1097/HRP.0000000000000411spa
dc.identifier.doi10.1097/HRP.0000000000000411
dc.identifier.issn1067-3229
dc.identifier.urihttp://hdl.handle.net/11268/13335
dc.language.isospaspa
dc.peerreviewedSispa
dc.relation.publisherversionhttp://doi.org/10.1097/HRP.0000000000000411spa
dc.rightsAttribution 4.0 International*
dc.rights.accessRightsopen accessspa
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoPsiquiatríaspa
dc.subject.unescoPsicosisspa
dc.subject.unescoPublicación científicaspa
dc.titleCariprazine and Cognition in Patients with Schizophrenia and Bipolar Disorder: A Systematic Revieweng
dc.typejournal articleeng
dspace.entity.typePublication
relation.isAuthorOfPublication2f14cdd7-3f29-44ba-b50a-c4b0c231081a
relation.isAuthorOfPublication.latestForDiscovery2f14cdd7-3f29-44ba-b50a-c4b0c231081a

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cariprazine and cognition in patients_2024.pdf
Size:
859.5 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Otras Áreas de Investigación de Salud